case_images: PMC5153495_01
case_images: Patient timeline from removal of pituitary adenoma to colon cancer diagnosis. GH, growth hormone; IGF-1, insulin-like growth factor 1; TSS, transsphenoidal surgery. aReference range, 109-329 ng/mL. bReference range, <=3 ng/mL.
case_images: CRIE2016-5156295.001.jpg
case_images: PMC5153495_01_CRIE2016-5156295.001.jpg
case_images: fig1
case_images: Three months before case presentation, transsphenoidal surgery was performed with resection of a pituitary adenoma (Figure 1).
case_images: PMC5153495_02
case_images: Patient timeline from removal of pituitary adenoma to colon cancer diagnosis. IGF-1, insulin-like growth factor 1; TSS, transsphenoidal surgery. aReference range, 70-205 ng/mL.
case_images: CRIE2016-5156295.002.jpg
case_images: PMC5153495_02_CRIE2016-5156295.002.jpg
case_images: fig2
case_images: The patient's IGF-1 levels were uncontrolled after surgery and ranged from 244 to 583 ng/mL (reference range, 70-205 ng/mL) during 16 months of lanreotide Autogel treatment (Figure 2).